Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

M.D. Anderson Cancer Center32 enrolled

Overview

The goal of this clinical research study is to learn if RecoverMI care can help to shorten the time that patients are in the hospital after surgery and if it can help them recover sooner. RecoverMI includes the following parts: * Preoperative Education * Early oral intake * Early mobilization * Telemedicine

Study Groups: If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. This is done because no one knows if one group is the same, better, or worse than the other group. * If you are assigned to Group 1, you will receive standard enhanced care after your surgery. * If you are assigned to Group 2, you will receive routine care after surgery, but you will also receive accelerated recovery, early discharge, and Telemedicine. Participants will be loaned an iPad to use for video-conferencing and text messaging in this study. This is an investigational study. The study doctor can explain how RecoverMI is designed to work. Up to 32 participants will be enrolled in this study. All will take part at MD Anderson.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Colorectal Cancer

Interventions

Accelerated Recovery PlanBEHAVIORAL

Early DischargeBEHAVIORAL

TelemedicineOTHER

Standard Enhanced CareBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patient has histologically proven colorectal cancer or polyp(s) that is planned to be treated by surgical resection performed with curative intent. 2. Patient is \>/= 18 years and younger than 80 years. 3. Elective minimally invasive operation. 4. No planned ostomy creation at time of enrollment. 5. Serum creatinine \<1.5 measured within 30 days of surgery. 6. Ability to speak, read, and understand English. Exclusion Criteria: 1. Strong, self-reported history of postoperative nausea and vomiting. 2. History of congestive heart failure. Systolic heart failure defined as Ejection Fraction (EF) \</= 40%), or diastolic heart failure defined as EF \>40% PLUS systemic manifestation of heart failure.

Locations (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

Outcomes

Primary Outcomes

Cumulative Hospital Length of Stay (LOS)

Time frame: 30 days post transplant

Secondary Outcomes

Failure Rate (FR) in the RecoverMI Arm

Time frame: 30 days

Patient Satisfaction

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.